...
首页> 外文期刊>Medicines >Effects of Shugan-Jianpi Recipe on the Expression of the p38 MAPK/NF-κB Signaling Pathway in the Hepatocytes of NAFLD Rats
【24h】

Effects of Shugan-Jianpi Recipe on the Expression of the p38 MAPK/NF-κB Signaling Pathway in the Hepatocytes of NAFLD Rats

机译:疏肝健脾方对NAFLD大鼠肝细胞p38 MAPK /NF-κB信号通路表达的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: In traditional Chinese medicine, the Shugan-Jianpi recipe is often used in the treatment of nonalcoholic fatty liver disease (NAFLD). This study aimed to explore the mechanism of the Shugan-Jianpi recipe in relation to rats with NAFLD induced by a high-fat diet. Methods: Rats were randomly divided into eight groups: normal group (NG), model group (MG), low-dose Chaihu–Shugan–San group (L-CG), high-dose Chaihu–Shugan–San group (H-CG), low-dose Shenling–Baizhu–San group (L-SG), high-dose Shenling–Baizhu–San group (H-SG), low dose of integrated-recipes group (L-IG), and high dose of integrated-recipes group (H-IG). After 26 weeks, a lipid profile, aspartate, and alanine aminotransferases in serum were detected. The serum levels of inflammatory factors including interleukin (IL)-1β, IL-6, and tumor necrosis factor-alpha (TNF-α) were analyzed using the enzyme linked immunosorbent assay (ELISA) method. Hepatic pathological changes were observed with hematoxylin-eosin (HE) and oil red O staining. The expression of the p38 mitogen-activated protein kinases (MAPK)uclear factor-κB (NF-κB) pathway was detected by quantitative real-time PCR and Western blotting. Results: A pathological section revealed that NAFLD rats have been successfully reproduced. Compared with the model group, each treatment group had different degrees of improvement. The Shugan-Jianpi recipe can inhibit the serum levels of IL-1β, IL-6, and TNF-α in NAFLD rats. The expression of mRNA and a protein related to the p38 MAPK/NF-κB signaling pathway were markedly decreased as a result of the Shugan-Jianpi recipe. Conclusions: The Shugan-Jianpi recipe could attenuate NAFLD progression, and its mechanism may be related to the suppression of the p38 MAPK/NF-κB signaling pathway in hepatocytes.
机译:背景:在传统中药中,疏肝健脾方常用于治疗非酒精性脂肪性肝病(NAFLD)。本研究旨在探讨疏肝健脾方对高脂饮食诱导的NAFLD大鼠的作用机理。方法:将大鼠随机分为八组:正常组(NG),模型组(MG),小剂量柴胡–舒肝–散组(L-CG),大剂量柴胡–舒肝–散组(H-CG) ),小剂量神灵-白竹-三组(L-SG),大剂量神灵-白竹-三组(H-SG),低剂量综合食谱组(L-IG)和高剂量综合-配方组(H-IG)。 26周后,检测到血清中的脂质分布,天冬氨酸和丙氨酸氨基转移酶。使用酶联免疫吸附法(ELISA)分析血清中白介素(IL)-1β,IL-6和肿瘤坏死因子-α(TNF-α)等炎症因子的水平。用苏木精-曙红(HE)和油红O染色观察肝病理变化。通过实时定量PCR和Western印迹检测p38丝裂原活化蛋白激酶(MAPK)/核因子-κB(NF-κB)通路的表达。结果:病理切片显示,NAFLD大鼠已成功繁殖。与模型组相比,每个治疗组均有不同程度的改善。疏肝健脾方能抑制NAFLD大鼠血清IL-1β,IL-6和TNF-α水平。 Shugan-Jianpi食谱的结果显着降低了与p38 MAPK /NF-κB信号通路相关的mRNA和蛋白的表达。结论:疏肝健脾方能减轻NAFLD的进展,其机制可能与抑制肝细胞中p38 MAPK /NF-κB信号通路有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号